Skip to main content
Premium Trial:

Request an Annual Quote

Clarient Shareholders Tender 80 Percent of Shares in GE Healthcare Acquisition

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stockholders of Clarient have tendered around 80 percent of their shares to GE Healthcare as the initial offering period for the acquisition closed last night.

GE Healthcare launched the $580 million acquisition offer for the molecular diagnostics and imaging firm in early November.

Aliso Viejo, Calif.-based Clarient is developing proprietary biomarkers and tests for profiling breast, prostate, lung, colon, and blood-based cancers. Last year, the firm acquired Applied Genomics, a molecular diagnostics firm that was developing the Mammostrat breast cancer recurrence test, which Clarient intends to launch as a laboratory-developed test later this year.

GE today said that it has been informed that 71,162,485 common shares and 5,263,158 preferred shares, representing 80.2 percent of Clarient's outstanding common stock, had been tendered and not withdrawn pursuant to the offer. In addition, GE has received commitments to tender 11,141,919 additional common shares, representing around 12.6 percent of the outstanding stock, under the guaranteed delivery procedure.

GE will now undertake a subsequent offering period to acquire all of the remaining shares that have not yet been tendered. That offering will end on midnight, New York City time, on Dec. 21.

Shareholders would receive the same amount in cash, $5 per share, as was paid in the initial offering period.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.